Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by nozzpackon Dec 17, 2020 12:09pm
172 Views
Post# 32128647

RE:Aphria And Tilray Mega-Merger Will Boom Or Bust

RE:Aphria And Tilray Mega-Merger Will Boom Or BustI dont see boooming but the $100 m inoperating savings will boost profit margins.
I sold half of my position this am, awaiting the end of taxloss selling.

I added more Hollister ( HOLL 24 cents )with the cash.

Virtually unknown, it will exit 2020 with an annual revenue runrate of $60 m CAD.
2021 will see massive expansion of its US assets, products and production capacity.

I estimate up to $300 million exit rate for 2021 and feel very comfortable with $150 m CADbout Alphamind Brands

What is very interesting is that its Alphamind Brands is a Canada- and U.S.-based growth-stage company developing a portfolio of legal mushroom-based natural health products as well as conducting R&D initiatives,   to explore psilocybin-based pharmaceutical treatments.

The company's ready-to-ship product SKUs include cordyceps, lion's mane, chaga and reishi mushroom-based liquid cordyceps, concentrated mushroom powder, tea and chocolate.

HOLL sells through 80 dispensaries in Arizona and 300 in California

The company's product SKUs under development include syrups, elixirs, cold beverages and nasal spray.
Sales begin in Q1 2021'

Looking at the very high valuations of these mushroom stocks , few of which have any sales, I see Alphamind as an excellent IPO once its sales base has been established in late 2021.

 
<< Previous
Bullboard Posts
Next >>